Cargando…
Clinicopathological and surgical comparisons of differentiated thyroid cancer between China and the USA: A multicentered hospital-based study
BACKGROUND: Thyroid cancer (TC), was the fastest-rising tumor of all malignancies in the world and China, predominantly differentiated thyroid cancer (DTC). However, evidence on TC stage distribution and influencing factors of late-stage were limited in China. METHODS: We carried out a retrospective...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9554273/ https://www.ncbi.nlm.nih.gov/pubmed/36249201 http://dx.doi.org/10.3389/fpubh.2022.974359 |
_version_ | 1784806656184418304 |
---|---|
author | Zhu, Juan Sun, Kexin Wang, Jian He, Yutong Li, Daojuan Liu, Shuzheng Huang, Yunchao Zhang, Min Song, Bingbing Liao, Xianzhen Liang, He Zhang, Qian Shi, Mumu Guo, Lanwei Zhou, Yongchun Lin, Yanping Lu, Yanni Tuo, Jiyu Xia, Yafen Sun, Huixin Xiao, Haifan Ji, Yong Yan, Ci Qiao, Jinwan Zeng, Hongmei Zheng, Rongshou Zhang, Siwei Liu, Shaoyan Chang, Sheng Wei, Wenqiang |
author_facet | Zhu, Juan Sun, Kexin Wang, Jian He, Yutong Li, Daojuan Liu, Shuzheng Huang, Yunchao Zhang, Min Song, Bingbing Liao, Xianzhen Liang, He Zhang, Qian Shi, Mumu Guo, Lanwei Zhou, Yongchun Lin, Yanping Lu, Yanni Tuo, Jiyu Xia, Yafen Sun, Huixin Xiao, Haifan Ji, Yong Yan, Ci Qiao, Jinwan Zeng, Hongmei Zheng, Rongshou Zhang, Siwei Liu, Shaoyan Chang, Sheng Wei, Wenqiang |
author_sort | Zhu, Juan |
collection | PubMed |
description | BACKGROUND: Thyroid cancer (TC), was the fastest-rising tumor of all malignancies in the world and China, predominantly differentiated thyroid cancer (DTC). However, evidence on TC stage distribution and influencing factors of late-stage were limited in China. METHODS: We carried out a retrospective study and enrolled TC patients who were first diagnosed and hospitalized in 8 hospitals in China in 2017. Logistic regression was used to evaluate associations between influencing factors and DTC stage. We extracted eligible primary DTC records newly diagnosed in 2017 from the USA's Surveillance, Epidemiology, and End Results (SEER) database. We compared clinicopathological features and surgical treatment between our DTC records and those from the SEER database. RESULTS: A total of 1970 eligible patients were included, with 1861 DTC patients with known stage. Among patients ≥45 years old, males (OR = 1.76, 95%CI 1.17–2.65) and those with new rural cooperative medical scheme insurance (NCMS) (OR = 1.99, 95%CI 1.38–2.88) had higher risks of late-stage DTC (stage III-IV). Compared with SEER database, over-diagnosis is more common in China [more DTC patients with onset age< 45 years old (50.3 vs. 40.7%, P < 0.001), with early-stage (81.2 vs. 76.0%, P < 0.001), and with tumors<2cm (74.9 vs. 63.7%, P < 0.001)]. Compared with the USA, TC treatment is more conservative in China. The proportion of lobectomy in our database was significantly higher than that in the SEER database (41.3 vs. 17.0%, P < 0.001). CONCLUSIONS: Unique risk factors are found to be associated with late-stage DTC in China. The differences in the aspect of clinicopathological features and surgical approaches between China and the USA indicate that potential over-diagnosis and over-surgery exist, and disparities on surgery extent may need further consideration. The findings provided references for other countries with similar patterns. |
format | Online Article Text |
id | pubmed-9554273 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-95542732022-10-13 Clinicopathological and surgical comparisons of differentiated thyroid cancer between China and the USA: A multicentered hospital-based study Zhu, Juan Sun, Kexin Wang, Jian He, Yutong Li, Daojuan Liu, Shuzheng Huang, Yunchao Zhang, Min Song, Bingbing Liao, Xianzhen Liang, He Zhang, Qian Shi, Mumu Guo, Lanwei Zhou, Yongchun Lin, Yanping Lu, Yanni Tuo, Jiyu Xia, Yafen Sun, Huixin Xiao, Haifan Ji, Yong Yan, Ci Qiao, Jinwan Zeng, Hongmei Zheng, Rongshou Zhang, Siwei Liu, Shaoyan Chang, Sheng Wei, Wenqiang Front Public Health Public Health BACKGROUND: Thyroid cancer (TC), was the fastest-rising tumor of all malignancies in the world and China, predominantly differentiated thyroid cancer (DTC). However, evidence on TC stage distribution and influencing factors of late-stage were limited in China. METHODS: We carried out a retrospective study and enrolled TC patients who were first diagnosed and hospitalized in 8 hospitals in China in 2017. Logistic regression was used to evaluate associations between influencing factors and DTC stage. We extracted eligible primary DTC records newly diagnosed in 2017 from the USA's Surveillance, Epidemiology, and End Results (SEER) database. We compared clinicopathological features and surgical treatment between our DTC records and those from the SEER database. RESULTS: A total of 1970 eligible patients were included, with 1861 DTC patients with known stage. Among patients ≥45 years old, males (OR = 1.76, 95%CI 1.17–2.65) and those with new rural cooperative medical scheme insurance (NCMS) (OR = 1.99, 95%CI 1.38–2.88) had higher risks of late-stage DTC (stage III-IV). Compared with SEER database, over-diagnosis is more common in China [more DTC patients with onset age< 45 years old (50.3 vs. 40.7%, P < 0.001), with early-stage (81.2 vs. 76.0%, P < 0.001), and with tumors<2cm (74.9 vs. 63.7%, P < 0.001)]. Compared with the USA, TC treatment is more conservative in China. The proportion of lobectomy in our database was significantly higher than that in the SEER database (41.3 vs. 17.0%, P < 0.001). CONCLUSIONS: Unique risk factors are found to be associated with late-stage DTC in China. The differences in the aspect of clinicopathological features and surgical approaches between China and the USA indicate that potential over-diagnosis and over-surgery exist, and disparities on surgery extent may need further consideration. The findings provided references for other countries with similar patterns. Frontiers Media S.A. 2022-09-28 /pmc/articles/PMC9554273/ /pubmed/36249201 http://dx.doi.org/10.3389/fpubh.2022.974359 Text en Copyright © 2022 Zhu, Sun, Wang, He, Li, Liu, Huang, Zhang, Song, Liao, Liang, Zhang, Shi, Guo, Zhou, Lin, Lu, Tuo, Xia, Sun, Xiao, Ji, Yan, Qiao, Zeng, Zheng, Zhang, Liu, Chang and Wei. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Public Health Zhu, Juan Sun, Kexin Wang, Jian He, Yutong Li, Daojuan Liu, Shuzheng Huang, Yunchao Zhang, Min Song, Bingbing Liao, Xianzhen Liang, He Zhang, Qian Shi, Mumu Guo, Lanwei Zhou, Yongchun Lin, Yanping Lu, Yanni Tuo, Jiyu Xia, Yafen Sun, Huixin Xiao, Haifan Ji, Yong Yan, Ci Qiao, Jinwan Zeng, Hongmei Zheng, Rongshou Zhang, Siwei Liu, Shaoyan Chang, Sheng Wei, Wenqiang Clinicopathological and surgical comparisons of differentiated thyroid cancer between China and the USA: A multicentered hospital-based study |
title | Clinicopathological and surgical comparisons of differentiated thyroid cancer between China and the USA: A multicentered hospital-based study |
title_full | Clinicopathological and surgical comparisons of differentiated thyroid cancer between China and the USA: A multicentered hospital-based study |
title_fullStr | Clinicopathological and surgical comparisons of differentiated thyroid cancer between China and the USA: A multicentered hospital-based study |
title_full_unstemmed | Clinicopathological and surgical comparisons of differentiated thyroid cancer between China and the USA: A multicentered hospital-based study |
title_short | Clinicopathological and surgical comparisons of differentiated thyroid cancer between China and the USA: A multicentered hospital-based study |
title_sort | clinicopathological and surgical comparisons of differentiated thyroid cancer between china and the usa: a multicentered hospital-based study |
topic | Public Health |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9554273/ https://www.ncbi.nlm.nih.gov/pubmed/36249201 http://dx.doi.org/10.3389/fpubh.2022.974359 |
work_keys_str_mv | AT zhujuan clinicopathologicalandsurgicalcomparisonsofdifferentiatedthyroidcancerbetweenchinaandtheusaamulticenteredhospitalbasedstudy AT sunkexin clinicopathologicalandsurgicalcomparisonsofdifferentiatedthyroidcancerbetweenchinaandtheusaamulticenteredhospitalbasedstudy AT wangjian clinicopathologicalandsurgicalcomparisonsofdifferentiatedthyroidcancerbetweenchinaandtheusaamulticenteredhospitalbasedstudy AT heyutong clinicopathologicalandsurgicalcomparisonsofdifferentiatedthyroidcancerbetweenchinaandtheusaamulticenteredhospitalbasedstudy AT lidaojuan clinicopathologicalandsurgicalcomparisonsofdifferentiatedthyroidcancerbetweenchinaandtheusaamulticenteredhospitalbasedstudy AT liushuzheng clinicopathologicalandsurgicalcomparisonsofdifferentiatedthyroidcancerbetweenchinaandtheusaamulticenteredhospitalbasedstudy AT huangyunchao clinicopathologicalandsurgicalcomparisonsofdifferentiatedthyroidcancerbetweenchinaandtheusaamulticenteredhospitalbasedstudy AT zhangmin clinicopathologicalandsurgicalcomparisonsofdifferentiatedthyroidcancerbetweenchinaandtheusaamulticenteredhospitalbasedstudy AT songbingbing clinicopathologicalandsurgicalcomparisonsofdifferentiatedthyroidcancerbetweenchinaandtheusaamulticenteredhospitalbasedstudy AT liaoxianzhen clinicopathologicalandsurgicalcomparisonsofdifferentiatedthyroidcancerbetweenchinaandtheusaamulticenteredhospitalbasedstudy AT lianghe clinicopathologicalandsurgicalcomparisonsofdifferentiatedthyroidcancerbetweenchinaandtheusaamulticenteredhospitalbasedstudy AT zhangqian clinicopathologicalandsurgicalcomparisonsofdifferentiatedthyroidcancerbetweenchinaandtheusaamulticenteredhospitalbasedstudy AT shimumu clinicopathologicalandsurgicalcomparisonsofdifferentiatedthyroidcancerbetweenchinaandtheusaamulticenteredhospitalbasedstudy AT guolanwei clinicopathologicalandsurgicalcomparisonsofdifferentiatedthyroidcancerbetweenchinaandtheusaamulticenteredhospitalbasedstudy AT zhouyongchun clinicopathologicalandsurgicalcomparisonsofdifferentiatedthyroidcancerbetweenchinaandtheusaamulticenteredhospitalbasedstudy AT linyanping clinicopathologicalandsurgicalcomparisonsofdifferentiatedthyroidcancerbetweenchinaandtheusaamulticenteredhospitalbasedstudy AT luyanni clinicopathologicalandsurgicalcomparisonsofdifferentiatedthyroidcancerbetweenchinaandtheusaamulticenteredhospitalbasedstudy AT tuojiyu clinicopathologicalandsurgicalcomparisonsofdifferentiatedthyroidcancerbetweenchinaandtheusaamulticenteredhospitalbasedstudy AT xiayafen clinicopathologicalandsurgicalcomparisonsofdifferentiatedthyroidcancerbetweenchinaandtheusaamulticenteredhospitalbasedstudy AT sunhuixin clinicopathologicalandsurgicalcomparisonsofdifferentiatedthyroidcancerbetweenchinaandtheusaamulticenteredhospitalbasedstudy AT xiaohaifan clinicopathologicalandsurgicalcomparisonsofdifferentiatedthyroidcancerbetweenchinaandtheusaamulticenteredhospitalbasedstudy AT jiyong clinicopathologicalandsurgicalcomparisonsofdifferentiatedthyroidcancerbetweenchinaandtheusaamulticenteredhospitalbasedstudy AT yanci clinicopathologicalandsurgicalcomparisonsofdifferentiatedthyroidcancerbetweenchinaandtheusaamulticenteredhospitalbasedstudy AT qiaojinwan clinicopathologicalandsurgicalcomparisonsofdifferentiatedthyroidcancerbetweenchinaandtheusaamulticenteredhospitalbasedstudy AT zenghongmei clinicopathologicalandsurgicalcomparisonsofdifferentiatedthyroidcancerbetweenchinaandtheusaamulticenteredhospitalbasedstudy AT zhengrongshou clinicopathologicalandsurgicalcomparisonsofdifferentiatedthyroidcancerbetweenchinaandtheusaamulticenteredhospitalbasedstudy AT zhangsiwei clinicopathologicalandsurgicalcomparisonsofdifferentiatedthyroidcancerbetweenchinaandtheusaamulticenteredhospitalbasedstudy AT liushaoyan clinicopathologicalandsurgicalcomparisonsofdifferentiatedthyroidcancerbetweenchinaandtheusaamulticenteredhospitalbasedstudy AT changsheng clinicopathologicalandsurgicalcomparisonsofdifferentiatedthyroidcancerbetweenchinaandtheusaamulticenteredhospitalbasedstudy AT weiwenqiang clinicopathologicalandsurgicalcomparisonsofdifferentiatedthyroidcancerbetweenchinaandtheusaamulticenteredhospitalbasedstudy |